Patents by Inventor Paul MORRILL

Paul MORRILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer
    Patent number: 11287416
    Abstract: The invention relates to cancer, and in particular to novel pharmaceutical compositions, therapies and methods for treating, preventing or ameliorating cancer, and especially metastatic disease. The invention also relates to diagnostic and prognostic methods for cancer and metastatic disease, and biomarkers for these conditions.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: March 29, 2022
    Assignee: NEURO-BIO LTD
    Inventors: Susan Adele Greenfield, Henry Tu, Paul Morrill, Sara Garcia-Rates, Chris Pepper, Chris Fegan
  • Antibody that recognises the T14 peptide of AChE
    Patent number: 10954306
    Abstract: The invention relates to antibodies, and in particular, to antibodies used in the diagnosis and treatment of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. The invention extends to methods of diagnosis and therapy of neurodegenerative disorders, and to assays and screens for isolating novel therapeutic compounds for treating such diseases.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: March 23, 2021
    Assignee: NEURO-BIO LTD
    Inventors: Susan Adele Greenfield, Sara Garcia-Rates, Paul Morrill
  • BIOMARKER
    Publication number: 20200271673
    Abstract: The invention relates to biomarkers for neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Huntington's disease or Motor Neurone disease. The invention especially relates to a novel quantitative predictive biomarker for cognitive decline, and in particular the rate of cognitive decline that a subject will suffer, for example as a result of developing a neurode-generative disorder. The invention further provides diagnostic and prognostic methods, and kits for predicting the rate of cognitive decline in subjects.
    Type: Application
    Filed: March 28, 2018
    Publication date: August 27, 2020
    Inventors: Susan GREENFIELD, Henry TU, Paul MORRILL, Sergio ROTONDO, Sara GARCIA-RATES
  • CANCER
    Publication number: 20190025289
    Abstract: The invention relates to cancer, and in particular to novel pharmaceutical compositions, therapies and methods for treating, preventing or ameliorating cancer, and especially metastatic disease. The invention also relates to diagnostic and prognostic methods for cancer and metastatic disease, and biomarkers for these conditions.
    Type: Application
    Filed: January 30, 2017
    Publication date: January 24, 2019
    Applicant: NEURO-BIO LTD
    Inventors: Susan GREENFIELD, Henry TU, Paul MORRILL, Sara GARCIA-RATES, Chris PEPPER, Chris FEGAN
  • ANTIBODY THAT RECOGNISES THE T14 PEPTIDE OF ACHE
    Publication number: 20180051094
    Abstract: The invention relates to antibodies, and in particular, to antibodies used in the diagnosis and treatment of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. The invention extends to methods of diagnosis and therapy of neurodegenerative disorders, and to assays and screens for isolating novel therapeutic compounds for treating such diseases.
    Type: Application
    Filed: March 23, 2016
    Publication date: February 22, 2018
    Inventors: Susan Adele GREENFIELD, Sara GARCIA-RATES, Paul MORRILL